期刊文献+

肺癌组织中内皮素1阳性表达及定量分析 被引量:5

Study on endothelin 1 positive expression and quantitative analysis in lung cancer
原文传递
导出
摘要 目的了解内皮素1(ET-1)在肺癌组织中表达及定量分析与肺癌分型、分级的关系。方法采用免疫组织化学ABC染色及图像分析技术测定ET-1阳性率及含量。结果104例不同类型肺癌ET-1阳性表达主要分布在胞浆内,腺癌、鳞癌和大细胞肺癌ET-1表达较高,分别为71.4%(20/28),57.1%(16/28)和40.0%(8/20)。小细胞肺癌表达低为21.4%(6/28)。对腺癌、鳞癌阳性表达的图像分析表明,肿瘤分化程度越低ET-1含量越高,分化程度越高ET-1含量越低。结论ET-1普遍存在于肺癌细胞中,腺癌和鳞癌高表达,表明ET-1含量与肿瘤分化程度有一定关系,ET-1可作为腺癌、鳞癌恶性生长的一个监测指标。 Objective In order to study endothelin 1(ET 1) positive expression in lung cancer and the relationship between the ET 1 quantitative analysis and the types, grades of lung cancer.Method ET 1 positive expression and quantitative analysis were detected using avidin biotin peroxidase complex method and image analysis technology. Result The ET 1 positive expression were mainly located in the cytoplasm in 104 cases with various types of lung cancer. The positive rate of ET 1 in adenocarcinoma, squamous cell carcinoma and large cell lung cancer were 71.4%, 57.1% and 40.0% respectively. The positive rate of ET 1 in small cell lung cancer was 21.4%, significantly lower than others. The results of image analysis on adenocarcinoma and squamous cell carcinoma showed that the lower lung cancer differentiation, the higher ET 1 quantitative. Conclusion There is ET 1 positive expression in all of types of lung cancer, but there is a high ET 1 positive expression in adenocarcinoma and squamous cell carcinoma. The results of image analysis indicated that ET 1 quantitive expression was somehow related to the differentiation degree of neoplasm, so ET 1 quantitative analysis may be as a monitoring index of adenocarcinoma and squamous cell carcinoma growing.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 1998年第2期111-113,共3页 Chinese Journal of Tuberculosis and Respiratory Diseases
关键词 肺肿瘤 免疫组织化学 内皮素 定量分析 Lung neoplasms Immunohistochemistry Endothelins
  • 相关文献

参考文献1

  • 1车东媛,肿瘤防治研究,1994年,21卷,2页

同被引文献42

  • 1熊瑛,王宋平,李国平,张光莹,彭启灿,范贤明,李万成.BALF中ET、CGRP变化与原发性支气管肺癌的相关性研究[J].现代临床医学生物工程学杂志,1997,3(1):41-42. 被引量:1
  • 2张弘,石磊.内皮素与肿瘤[J].综合临床医学,1996,12(1):5-6. 被引量:3
  • 3[1]Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent Vasoconstrictor peptide produced by Vascular endothelial cells. Nature, 1988; 332(6163): 411 ~415
  • 4[2]Michael JR, Markewitz BA. Endothelins and the lung. Am J Respir Crit Care Med, 1996; 154(3): 555~581
  • 5[3]Bames PJ. Endothelins and pulmonary diseases. J Appl Physiol, 1994; 77(3): 1051~1059
  • 6[4]Fagan KA, Mcmurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res, 2001; 2 (2):90~101
  • 7[11]Giaid A, Hamid QA, Springall DR, et al. Detection of endothelin immunoreactivity and mRNA in pulmonary tumours. J pathol, 1990; 162(1): 15~22
  • 8[12]Ahmed SI, Thompson J, Coulson JM, et al. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol, 2000; 22(4): 422~431
  • 9[14]Shichiri M, Hirata Y, Vakajima T, et al. Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. Clin Invest, 1991; 87:1867~1871
  • 10[15]Dawas K, Loizidou M, Shankar A, et al. Angiogenesis in cancer: the role of endothelin-1. Ann R Coil Surg Engl, 1999; 81(5): 306~331

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部